BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2014
View Archived Issues
FDA grants orphan drug status to Re-188-P2045 for pancreatic cancer
Read More
TiGenix to develop allogeneic stem cell therapy for early RA and sepsis
Read More
Aclaris Therapeutics reports data from phase II trial of A-101 in seborrheic keratosis
Read More
FDA grants orphan drug status to two pulmonary disease treatments
Read More
VIB and Spain's CNIO partner for drug discovery
Read More
FDA grants small business waver of PDUFA fee for Rockwell's Triferic
Read More
Xenetic Biosciences reports safety data from ongoing phase II study of ErepoXen
Read More
Italian researchers patent novel LSD1 inhibitors
Read More
Novel SYK inhibitors prepared by Hutchison MediPharma
Read More
Roche designs new immunoproteasome inhibitors
Read More
Roche prepares new CB2 receptor agonists
Read More
Boehringer Ingelheim discloses novel GPR40 agonists
Read More
University of Bath designs novel products for cancer
Read More
Phase II study of DARPin abicipar pegol supports progressing to phase III
Read More
Phase I data reported for REGN-1400 in patients with cancer
Read More
Hanmi Pharmaceuticals and Kinex Pharmaceuticals report data from phase I/II trial of Oraxol
Read More
Clinical trial of cancer vaccine ETBX-011 completed
Read More
Vertex submits sNDA for Kalydeco in adults with CF and the R117H mutation
Read More
IND application submitted for ProHema in inherited metabolic disorders
Read More
Imaging neuroinflammation with a novel PET tracer
Read More
Amicus provides update on second phase III study of migalastat for Fabry disease
Read More
ISIS-GCGRRx improves glycemic control in type 2 diabetes trial
Read More
Ipsen submits applications in the U.S. and E.U. for Somatuline
Read More
BioAlliance Pharma and Topotarget approve merger to create Onxeo
Read More
Actavis completes acquisition of Forest Laboratories, Furiex in favor of its acquisition
Read More
FDA awards breakthrough therapy designation to blinatumomab in ALL
Read More